Unité de Recherche en Biologie et Epidémiologie Parasitaires (URBEP)-UMR6236-IFR48, Antenne Marseille de l'Institut de Recherche Biomédicale des Armées (IRBA), BP 60109, 13262 Marseille Cedex 07, France.
Malar J. 2010 Oct 11;9:276. doi: 10.1186/1475-2875-9-276.
Plasmodium falciparum infections could lead to severe malaria, principally in non-immune individuals as children and travellers from countries exempted of malaria. Severe malaria is often associated with the sequestration of P. falciparum-infected erythrocytes in deep micro-vascular beds via interactions between host endothelial receptors and parasite ligands expressed on the surface of the infected erythrocyte. Although, serological responses from individuals living in endemic areas against proteins expressed at surface of the infected erythrocyte have been largely studied, seldom data are available about the specific targets of antibody response from travellers.
In order to characterize antigens recognized by traveller sera, a comparison of IgG immune response against membrane protein extracts from uninfected and P. falciparum-infected red blood cells (iRBC), using immunoblots, was performed between non exposed individuals (n = 31) and briefly exposed individuals (BEI) (n = 38) to malaria transmission.
Immune profile analysis indicated that eight protein bands from iRBC were significantly detected more frequently in the BEI group. Some of these antigenic proteins were identified by an original immuno-proteomic approach.
Collectively, these data may be useful to characterize the singular serological immune response against a primary malaria infection in individuals briefly exposed to transmission.
疟原虫感染可导致严重疟疾,主要发生在无免疫力的人群中,如儿童和来自无疟疾国家的旅行者。严重疟疾常与疟原虫感染的红细胞通过宿主内皮受体与感染红细胞表面表达的寄生虫配体之间的相互作用而在深部微血管床中被隔离有关。尽管在流行地区居住的个体针对感染红细胞表面表达的蛋白的血清学反应已得到广泛研究,但有关旅行者抗体反应的特定靶标数据很少。
为了描述旅行者血清中识别的抗原,我们使用免疫印迹法比较了未暴露个体(n=31)和疟疾传播短暂暴露个体(BEI)(n=38)对未感染和疟原虫感染红细胞(iRBC)膜蛋白提取物的 IgG 免疫反应。
免疫谱分析表明,BEI 组中 iRBC 中有 8 个蛋白条带的检出频率明显更高。通过一种原始的免疫蛋白质组学方法鉴定了其中一些抗原性蛋白。
总的来说,这些数据可用于描述短暂接触传播的个体中初次疟疾感染的独特血清免疫反应。